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Abstract: INTRODUCTION: In this study, we assessed the relationship of insular strokes and plasma
MR-proANP levels with newly diagnosed atrial fibrillation (NDAF). METHODS: This study is based on
a prospective acute stroke cohort (http://www.clinicaltrials.gov, NCT00390962). Patient eligibility was
dependent on the diagnosis of acute ischemic stroke, absence of previous stroke based on past medical
history and MRI, no history of AF and congestive heart failure (cohort A) and, additionally, no stroke
lesion size ￿ 20 mL (sub-cohort A*). AF, the primary endpoint, was detected on 24-hour electrocardiog-
raphy and/or echocardiography. Involvement of the insula was assessed by two experienced readers on
MRI blinded to clinical data. MR-proANP levels were obtained through a novel sandwich immunoassay.
Logistic-regression-models were fitted to estimate odds ratios for the association of insular strokes and
MR-proANP with NDAF. The discriminatory accuracy of insular strokes and MR-proANP was assessed
by a model-wise comparison of the area under the receiver-operating-characteristics-curve (AUC) with
known predictors of AF. RESULTS: 104 (cohort A) and 83 (cohort A*) patients fulfilled above-mentioned
criteria. Patients with isolated insular strokes had a 10.7-fold higher odds of NDAF than patients with
a small ischemic stroke at any other location. The AUC of multivariate logistic regression models for
the prediction of NDAF improved significantly when adding stroke location and MR-proANP levels.
Moreover, MR-proANP levels remained significantly elevated throughout the acute hospitalization pe-
riod in patients with NDAF compared to those without. CONCLUSIONS: Isolated insular strokes and
plasma MR-proANP levels on admission are independent predictors of NDAF and significantly improve
the prediction accuracy of identifying patients with NDAF compared to known predictors including age,
the NIHSS and lesion size. To accelerate accurate diagnosis and enhance secondary prevention in acute
stroke, higher levels of MR-proANP and insular strokes may represent easily accessible indicators of AF
if confirmed in an independent validation cohort.
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Abstract
Introduction: In this study, we assessed the relationship of insular strokes and plasma MR-proANP levels with newly
diagnosed atrial fibrillation (NDAF).
Methods: This study is based on a prospective acute stroke cohort (http://www.clinicaltrials.gov, NCT00390962). Patient
eligibility was dependent on the diagnosis of acute ischemic stroke, absence of previous stroke based on past medical
history and MRI, no history of AF and congestive heart failure (cohort A) and, additionally, no stroke lesion size $ 20 mL
(sub-cohort A*). AF, the primary endpoint, was detected on 24-hour electrocardiography and/or echocardiography.
Involvement of the insula was assessed by two experienced readers on MRI blinded to clinical data. MR-proANP levels were
obtained through a novel sandwich immunoassay. Logistic-regression-models were fitted to estimate odds ratios for the
association of insular strokes and MR-proANP with NDAF. The discriminatory accuracy of insular strokes and MR-proANP was
assessed by a model-wise comparison of the area under the receiver-operating-characteristics-curve (AUC) with known
predictors of AF.
Results: 104 (cohort A) and 83 (cohort A*) patients fulfilled above-mentioned criteria. Patients with isolated insular strokes
had a 10.7-fold higher odds of NDAF than patients with a small ischemic stroke at any other location. The AUC of
multivariate logistic regression models for the prediction of NDAF improved significantly when adding stroke location and
MR-proANP levels. Moreover, MR-proANP levels remained significantly elevated throughout the acute hospitalization period
in patients with NDAF compared to those without.
Conclusions: Isolated insular strokes and plasma MR-proANP levels on admission are independent predictors of NDAF and
significantly improve the prediction accuracy of identifying patients with NDAF compared to known predictors including
age, the NIHSS and lesion size. To accelerate accurate diagnosis and enhance secondary prevention in acute stroke, higher
levels of MR-proANP and insular strokes may represent easily accessible indicators of AF if confirmed in an independent
validation cohort.
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Introduction
The insular cortex plays an important role in the regulation of
the autonomic nervous system. Stimulation of the right insula
provokes sympathetic cardiovascular effects, whereas stimulation
of the left insula leads to parasympathetic effects.[1] Insular
damage has been associated with newly-detected atrial fibrillation
(NDAF), atrioventricular blocks and an increased amount of
ectopic beats.[2] Furthermore, insular damage is associated with
adverse cardiac outcome such as sudden cardiac death and
congestive heart failure.[3–5].
A-type natriuretic peptides (ANP) have been proposed as
biomarkers for atrial fibrillation (AF) and midregional-proANP
plasma levels correlate with the duration of AF episodes.[6,7]
There are several sandwich immunoassays commercially available
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that measure the concentrations of ANP and its precursor protein
proANP in human plasma; however, most are prone to
fragmentation and may underestimate the release of the precursor
due to the early degradation of crucial epitopes at the extreme
ends of the molecule. [8,9] The MR-proANP assay used in this
study was designed to detect the mid-region of the prohormone,
Figure 1. Patient flow chart. The upper part of the figure (as divided by 2 horizontal bars) denotes the study cohort of the original COSMOS cohort
as previously described.[11] The lower part of the scheme indicates the eligibility criteria for the cohorts analyzed in this study.
doi:10.1371/journal.pone.0092421.g001
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which is more stable than the N- or C-terminal part of the
precursor. [10].
The aim of this study was to analyse the predictive value of isolated
infarcts affecting the insular cortex in identifying patients with newly
diagnosed atrial fibrillation (NDAF) during the acute hospitalization
period from a large, prospectively collected stroke cohort.[11] In a
second step, we aimed to investigate the putative role of plasmaMR-
proANP levels in predicting NDAF and its potential additive value
compared to stroke location and other known predictors. Early and
accurate identification of stroke patients at high risk for AF is
important in selecting candidates for intensive cardiac monitoring
such as implantable loop recorders. [12].
Patients and Methods
Ethics Statement
This study was based on a prospective cohort study (clinical
trial registration at http://www.clinicaltrials.gov, number NCT
00390962) at the University Hospital Basel, Basel, Switzerland.
The Ethics Committee of Basel, Switzerland, approved the study
protocol and informed, written consent was obtained from all
patients before enrollment. A complete description of the cohort
has been reported previously.[11].
Description of subjects
Briefly, from 11/2006 to 11/2007, all patients with a suspected
acute ischemic cerebrovascular event were consecutively screened
for enrollment in the study. All patients admitted to the emergency
department within 72 hours after stroke onset with an acute
ischemic stroke defined according to the World Health Organi-
zation criteria were included. [13] Stroke severity on admission
was assessed by stroke neurologists (MK, FF) using the National
Institutes of Health Stroke Scale (NIHSS). All patients underwent
a standardized diagnostic workup including brain computer
tomography mainly to exclude intracranial hemorrhage, magnetic
resonance imaging (MRI), standard 12-lead electrocardiography
and/or 24-hour electrocardiography. Echocardiography and
neurosonographic studies of the extracranial and intracranial
arteries were obtained in order to classify stroke etiology according
to the TOAST criteria.[14] Initially, from 605 patients with
suspected cerebrovascular events admitted to the emergency
department of the University Hospital of Basel, 362 patients with
confirmed ischemic stroke were selected (see also figure 1). From
this cohort, we excluded 258 patients due to positive personal
history of congestive heart disease and/or atrial fibrillation
(n= 209), those with no imaging data on MRI due to death
Table 1. Baseline characteristics of patient cohorts as described in figure 1.
Cohort A
INS No INS p-value NDAF No NDAF p-value
number of patients, n 18 86 13 91
age [y], median (IQR) 72 (57 – 77) 68 (59 – 79) 0.98 71 (67 – 81) 68 (59 – 77) 0.13
NIHSS [pts], median (IQR) 11 (4 – 15) 4 (2 – 7) 0.0019* 5 (2 – 16.5) 4 (2 – 8) 0.28
female sex, % (n) 56 (10) 38 (33) 0.18 38 (5) 42 (38) 0.82
systolic blood pressure [mmHg], median (IQR) 144 (130 – 170) 168 (140 – 183) 0.10 164 (141 – 184) 166 (141 – 185) 0.88
heart rate, median [min21] (IQR) 73 (64 – 89) 68 (75 – 89) 0.66 64 (71 – 78) 76 (67 – 90) 0.31
history of coronary artery disease, % (n) 17 (3) 21 (18) 0.68 15 (2) 21 (19) 0.64
history of arterial hypertension, % (n) 78 (14) 79 (68) 0.78 77 (10) 74 (67) 0.80
lesion size on DWI [mL], median (IQR) 45.3 (9.8 – 100.5) 0.9 (0.1 – 4.1) , 0.0001* 16.4 (2.8 – 91.1) 1.2 (0.1 – 6.6) 0.0012*
MR-proANP on admission [pM], median (IQR) 151.0 (102.1 – 255.8) 98.5 (68.7 – 169.0) 0.04* 207.0 (122.5 – 341.0) 98.1 (67.5 – 161.3) 0.0004*
Involvement of the insular cortex, % (n) n/a n/a 38 (5) 14 (13) 0.03*
Newly-diagnosed atrial fibrillation, % (n) 28 (5) 9 (8) 0.03* n/a n/a
Cohort A*
INS No INS p-value NDAF No NDAF p-value
number of patients, n 7 76 8 75
age [y], median (IQR) 65 (59 – 78) 68 (59 – 79) 0.86 70 (66 – 81) 67 (59 – 78) 0.35
NIHSS [pts], median (IQR) 4 (2 – 8) 4 (1 – 7) 0.70 4 (1 – 10) 4 (2 – 7) 0.89
female sex, % (n) 43 (3) 38 (29) 1 38 (3) 40 (30) 0.89
systolic blood pressure [mmHg], median (IQR) 162 (130 – 184) 163 (143 – 186) 0.57 162 (135 – 184) 168 (143 – 186) 0.66
heart rate, median [min21] (IQR) 87 (65 – 90) 79 (67 – 90) 0.89 74 (65 – 88) 76 (67 – 90) 0.91
history of coronary artery disease, % (n) 14 (1) 21 (16) 0.67 13 (1) 21 (16) 0.56
history of arterial hypertension, % (n) 86 (6) 70 (53) 0.47 75 (6) 71 (53) 1
MR - proANP on admission [pM], median (IQR) 122.0 (87.5 – 174.0) 98.0 (69.1 – 162.0) 0.48 195.5 (113.5 – 398.3) 93.4 (67.5 – 146.5) 0.0031*
Involvement of the insular cortex, % (n) n/a n/a 38 (3) 5 (4) 0.0019*
Newly-diagnosed atrial fibrillation, % (n) 43 (3) 7 (5) 0.0019* n/a n/a
(INS = insular stroke, NDAF = newly diagnosed atrial fibrillation, NIHSS = National Institute of Health Stroke Scale, IQR = Interquartile Range, CAD = coronary artery
disease).*p,0.05.
doi:10.1371/journal.pone.0092421.t001
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during hospitalization, early discharge/transferal to another
hospital or due to contraindications to MR imaging (n = 42) and
those without diagnostic cardiological work-up due to early death
during hospitalization or early discharge or transferal to another
ward (n = 7). In a second step only patients with ischemic strokes of
lesion sizes under 20 mL were selected (see below) yielding a
cohort of n= 83.
Neuroimaging and lesion size stratification
MRI (T1-, T2-, DWI) sequences and MR angiography was
performed in all patients using a 1.5-Tesla MR Avanto system
(Siemens, Erlangen, Germany). Involvement of the insular cortex
was assessed on DWI and T2-weighted images by two experienced
readers unaware of clinical data. Stroke lesion volumes on DWI
were calculated by the commonly used semiquantitative meth-
od.[15] The insula was defined as the cortical region covered by
the frontoparietal operculum and the superior temporal plane and
overlying the extreme capsule and the claustrum. To obtain an
estimate about the volume of the insular cortex, we performed a
meta-analysis in the Internet Brain Volume Database for in vivo
volumetric studies of non-diseased humans.[16] The query yielded
11 studies with a total of 709 investigated subjects. A cumulative
meta-analysis using a random effects model for insular volume
returned an estimated size of 11.38 mL (95% CI 10.12–
12.64 mL). Additionally, previously conducted studies on insular
strokes with published lesion sizes showed volumes of insular
strokes ranging from around 30 mL [5] to 40-60 mL [4]. Taking
these limits as well as our sample size into account we selected a
lesion threshold of 20 mL on DWI for insular strokes.
Assays
Blood was obtained from a venous catheter and plasma was
frozen at 70uC. MR-proANP was measured in a blinded batch
analysis from all patients using a new sandwich immunoassay
(B.R.A.H.M.S. AG), Hennigsdorf/Berlin, Germany), as described
in detail elsewhere.[11] In brief, the lower detection limit of the
assay is 6.0 pmol/L. The intraassay coefficient of variation was
10%. The interassay coefficient of variation was 10%. In 325
healthy individuals, the range of MR-proANP concentrations was
9.6 to 313 pmol/L. The median was 45 pmol/L (95% confidence
interval [CI]: 43.0 to 49.1 pmol/L).
Statistical analysis
Baseline demographic, clinical observation, laboratory and
outcome data were compared between patients with and without
insular involvement as well as between those with newly-diagnosed
atrial fibrillation and those without. Discrete variables are
expressed as frequency (percentage) and continuous variables as
medians and interquartile ranges (IQR). For two group compar-
ison, we used Mann–Whitney U test and Chi-squared tests
depending on the variable type and distribution of the variable.
MR-proANP was ln-transformed to achieve a normal distribution
of the variable. One-way ANOVA analysis of variance was used
for multi-group comparisons of normally distributed variables with
Bonferroni correction of significance for multiple testing. In order
to choose the best predictive model to assess the discriminatory
value of insular strokes and/or MR-proANP for newly diagnosed
atrial fibrillation, we first performed univariate logistic regression
analyses for already established predictors of NDAF.[17] Second-
ly, all variables that were significantly associated (i.e. at a p-value
,0.10) with the outcome of interest (i.e. presence of new AF yes/
no) in the univariate analysis were then included in a multivariate
logistic regression analysis to assess their independent predictive
value. The area under the receiver operating characteristic curve
(AUC) was calculated to assess the discriminatory value of insular
strokes and/or MR-proANP to distinguish patients with NDAF
from patients without. The incremental predictive value of insular
strokes and/or MR-proANP was tested by comparing the AUC
between ‘‘model 1’’ (including all variables that have shown a
significant association in the univariate logistic regression model)
with the AUC of the nested models 2 and 3 (model 1 plus insular
strokes = model 2; or model 3 = model 2 plus MR-proANP).
Analogous calculations for comparison of the AUC in cohort A*
are marked as model 1* (isolated insular strokes) and 2* (model 1*
plus MR-proANP). For comparisons of these 3 and 2 models,
respectively, we used the likelihood-ratio test as recommended
[18]. Statistical analyses were undertaken using GraphPad Prism 5
(GraphPad Software, La Jolla, USA),IBM SPSS Statistics 20 (IBM,
New York, USA), Comprehensive Meta-Analysis (Biostat, Englewood,
USA) and custom-written scripts for MATLAB (MathWorks, Natick,
USA). Testing was always two-sided and P values less than 0.05 were
considered to indicate statistical significance.
Results
Study cohorts
We analyzed all patients from a large, prospective stroke study
cohort with a known negative history of congestive heart failure
and atrial fibrillation that have undergone a diagnostic cardiolog-
ical work-up on admission and in whom diffusion-weighted
imaging was available for volumetric analyses, yielding cohort
A.[11] In a second step, 21 patients were excluded from cohort A
due to a ischemic stroke lesion size$ 20 mL on diffusion-weighted
imaging to be able to selectively assess the impact of isolated
insular strokes, yielding cohort A*. The detailed baseline
characteristics of the cohorts A and A* analyzed in this study
are given in table 1.
Isolated insular strokes are independent predictors of
newly-diagnosed atrial fibrillation
Of 104 patients taken from the original study cohort that were
included for this analysis, 17% (n= 18) suffered from an ischemic
stroke involving the insular cortex while it was spared in 83%
Table 2. Predictors of newly-diagnosed atrial fibrillation in
cohort A.
Risk factor OR 95% CI p-Value
Age [y] 1.04 0.99 – 1.10 0.12
NIHSS [pts] 1.08 0.99 – 1.18 0.07?
Female sex (n) 0.87 0.27 – 2.87 0.82
Systolic blood pressure
[mmHg]
1.00 0.98 – 1.03 0.77
Pulse [min21] 0.98 0.95 – 1.02 0.38
Coronary artery disease (n) 0.69 0.14 – 3.38 0.65
Arterial hypertension (n) 1.19 0.30 – 4.71 0.80
Lesion size [mL] 1.01 1.00 – 1.02 0.02*
Involvement of the
insular cortex
3.75 1.06 – 13.20 0.04*
LnMR-proANP on
admission
5.03 1.86 – 13.56 0.001*
Univariate logistic regression, ?p,0.10, *p,0.05.
doi:10.1371/journal.pone.0092421.t002
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(n = 86) of patients (for detailed baseline characteristics see also
table 1, cohort A). In univariate logistic regression analysis, stroke
severity on admission (as determined by the NIHSS), lesion size on
DWI, involvement of the insular cortex and lnMR-proANP levels
on admission were significant predictors of newly diagnosed atrial
fibrillation in cohort A (p,0.10 for all predictors, table 2).
Compared to the other predictors, involvement of the insular
cortex in ischemic stroke patients failed to improve the predictive
value for NDAF (tables 3, 4). However to better investigate the
association of insular involvement with NDAF we hence chose to
introduce a cut-off for isolated insular strokes based on a
cumulative meta-analysis of insular cortex volumes (see also
materials and methods, [16]) and analyzed the association of
insular location with NDAF only in strokes of ,20 mL
including the insula (i.e. cohort A*). Herein, 8% (n = 7) of
the patients suffered from an isolated insular stroke, while the
insula was spared in 92% (n = 76) of patients. Of 7 patients
with isolated insular strokes, 43% were diagnosed with NDAF
(n = 3) while it was diagnosed in 7% of those without isolated
insular strokes (n = 4). In univariate logistic regression analysis
patients with isolated insular strokes were at 10-fold higher
odds for NDAF than those without affection of the insula (OR
10.65, 95% CI 1.85–61.3, p,0.01, table 5). In subsequent
multivariate logistic regression analysis of cohort A* isolated
insular strokes remained an independent predictor of NDAF
(OR 13.89, 95% CI 1.79–107.55, p,0.012, table 6) with an
area under the receiver operating characteristic curve of 0.66,
95% CI 0.43–0.89 (table 7). Moreover, adding isolated insular
strokes to the predictive model including only MRproANP-
levels (in cohort A*), improved the prediction capacity (AUC
0.81 [95% CI 0.68 – 0.93] for lnMR-proANP levels on
admission vs. 0.86 [95% CI 0.73 – 0.98] for lnMR-proANP
levels on admission and isolated insular strokes, p = 0.013,
likelihood-ratio test).
Figure 2. Timecourse of plasma MR-proANP levels. Plasma lnMR-proANP levels are plotted on the ordinate, lnMR-proANP levels were
significantly different between patient groups throughout the monitored period (day 0 denotes the day of admission; ** p,0.01, *** p,0.001, one-
way ANOVA with Bonferroni’s multiple comparisons post-hoc test). The abscissa denotes the time points of plasma MR-proANP levels during the
hospitalization period in patients with no newly-diagnosed atrial fibrillation (no NDAF, blue boxes) and those with newly-diagnosed atrial fibrillation
(NDAF, red boxes). Horizontal bars indicate group means with error bars denoting 95% CI.
doi:10.1371/journal.pone.0092421.g002
Table 3. Predictors of newly-diagnosed atrial fibrillation in
cohort A.
Model 1
Risk factor OR 95% CI p-Value
NIHSS 1.04 0.93 – 1.15 0.51
Lesion size [mL] 1.01 1.00 – 1.02 0.11
Model 2
Risk factor OR 95% CI p-Value
NIHSS 1.03 0.92 – 1.15 0.60
Lesion size [mL] 1.01 1.00 – 1.02 0.19
Involvement of the insular
cortex
2.28 0.57 – 9.20 0.25
Model 3
Risk factor OR 95% CI p-Value
NIHSS 0.97 0.85 – 1.11 0.69
Lesion size [mL] 1.01 1.00 – 1.02 0.14
Involvement of the insular
cortex
1.04 0.93 – 1.15 0.51
LnMR-proANP on admission 4.69 1.58 – 13.88 0.005*
Multivariate logistic regression, *p,0.05.
doi:10.1371/journal.pone.0092421.t003
Table 4. Comparison of the area under the receiver operating
characteristic curve of each model in cohort A.
Model AUC 95% CI
p-value for
comparison
1 0.69 0.54 – 0.83 n/a
2 0.74 0.6 – 0.88 0.26
3 0.85 0.75 – 0.94 0.002*
*p,0.05.
doi:10.1371/journal.pone.0092421.t004
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Plasma MR-proANP measured on admission is an
independent predictor of newly-diagnosed atrial
fibrillation
In univariate logistic regression analysis, lnMR-proANP levels
on admission showed a significant association with NDAF (cohort
A, OR 5.03, 95% CI 1.86–13.56, p= 0.001, table 2). In subsequent
multivariate logistic regression models, lnMR-proANP levels on
admission were independently associated with NDAF (OR 4.69,
95% CI 1.58–13.88, p= 0.005, table 3). LnMR-proANP levels on
admission improved the predictive accuracy for NDAF in cohort
A as determined by the comparison of the area under the receiver
operating characteristic curve (p= 0.002, likelihood-ratio test, table
4), an effect that was also observable in cohort A* (p = 0.013,
likelihood-ratio test, table 7). A cut-off value of 98.35 pM for
plasma levels of MR-proANP corresponded to a detection
sensitivity for NDAF of over 92.3%, thus in patients with levels
below 98.4 pM atrial fibrillation is highly unlikely. A specificity of
.98.9% was obtained at plasma levels over 538.5 pM, thus in
these patients detection of atrial fibrillation is almost certain.
LnMR-proANP levels stayed significantly different between
patients with NDAF and those without throughout the monitored
time course (p,0.001, day 0 [i.e. the day of admission]; p,0.01,
day 1; p,0.001, day 3 and p,0.01, day 5; one-way ANOVA with
Bonferroni’s post-hoc adjustment of significance, figure 2).
The association of MR-proANP and insular strokes
Although patients with strokes involving the insular cortex from
cohort A did have higher MR-proANP levels on admission than
those without (insular strokes 151.0 pM IQR 102.1–255.8 vs. non-
insular strokes 98.5 pM IQR 68.7–169.0, p= 0.04, Mann Whitney
U Test, table 1), after adjusting for lesion size, MR-proANP levels
were no longer associated with isolated insular strokes (in cohort A*).
Discussion
In this study, we found that patients with isolated insular strokes
(i.e. ischemic strokes of the insula with a volume,20 mL on DWI)
were at 10.7-fold higher odds for NDAF than those without.
Insular location significantly improved the predictive model to
identify NDAF when compared with other prognostic factors.
Moreover we found that higher levels of lnMR-proANP were
associated with 5.2-fold higher odds of newly detected AF. In
addition, the inclusion of lnMR-proANP levels in to the existing
predictive model (including insular stroke) further improved
differentiation between patients with NDAF and patients without
NDAF.
In line with our findings, involvement of the insula in ischemic
stroke patients was previously shown to be associated with severe
cardiac derangement leading to complex ECG abnormalities such
as premature ventricular contractions, non-sustained ventricular
tachycardia and others when compared to ischemic stroke patients
without insular involvement. Herein, especially right-sided insular
lesions were associated with newly detected cardiac arrhythmia.[5]
In another study with a smaller patient cohort, a greater increase
in plasma norepinephrine concentrations was observed in patients
with insular infarctions when compared to non-insular stroke
patients, thus suggesting a possible direct connection of the insular
lesion to activation of the sympathetic nervous system.[19] Lesion
sizes of investigated subjects in the former study added up to
30 mL on average, while the latter did not adjust for lesion size at
all. However, a cumulative analysis of insular volume in non-
diseased patients yielded an average size of 11.38 mL (95% CI
10.12 – 12.64 mL, [16]). Above-mentioned lesions (i.e. .30 mL)
are thus highly likely to affect other brain structures in the
immediate anatomical neighborhood that are also described as
regulators of the brain-heart-axis amongst others the caudate
nucleus and the ventromedial prefrontal cortex.[20] In contrast to
our study where lesion sizes was restricted to 20 mL (i.e. cohort
A*) the results of these other studies might lack specificity.
Patients with AF, especially when undiagnosed and/or untreat-
ed are more prone to cardiovascular complications such as
myocardial infarctions and thromboembolic events such as
strokes.[21] In a prospective study with a larger cohort, patients
with ischemic infarcts of the left insula were followed-up over 1
year and screened for sudden cardiac death, myocardial infarction
and congestive heart failure. When compared to patients with
non-insular infarcts and TIAs, left insular strokes were associated
with an increased risk for adverse cardiac outcome as well as
Table 5. Predictors of newly-diagnosed atrial fibrillation in
cohort A*.
Risk factor OR 95% CI p-Value
Age [y] 1.03 0.97 – 1.09 0.34
NIHSS [pts] 1.02 0.89 – 1.17 0.74
Female sex (n) 0.90 0.20 – 4.05 0.89
Systolic blood pressure
[mmHg]
1.00 0.97 – 1.03 0.79
Pulse [min21] 1.00 0.95 – 1.04 0.91
Coronary artery disease (n) 0.53 0.06 – 4.60 0.56
Arterial hypertension (n) 1.25 0.23 – 6.65 0.80
Isolated insular stroke 10.65 1.85 – 61.30 0.008#
LnMR-proANP on
admission
5.18 1.60 – 16.75 0.006#
Univariate logistic regression, #p,0.05.
doi:10.1371/journal.pone.0092421.t005
Table 6. Predictors of newly-diagnosed atrial fibrillation in
cohort A*.
Model 1*
Risk factor OR 95% CI p-Value
Isolated insular stroke 10.65 1.85 – 61.30 0.008#
Model 2*
Risk factor OR 95% CI p-Value
Isolated insular stroke 13.89 1.79 – 107.55 0.012#
LnMR-proANP on admission 6.00 1.61 – 22.37 0.008#
Multivariate logistic regression, #p,0.05.
doi:10.1371/journal.pone.0092421.t006
Table 7. Comparison of the area under the receiver operating
characteristic curve of each mode in cohort A*.
Model AUC 95% CI
p-value for
comparison
1* 0.66 0.43– 0.89 n/a
2* 0.86 0.73 – 0.98 0.013#
#p,0.05.
doi:10.1371/journal.pone.0092421.t007
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impaired cardiac wall motion. The exclusion of TIAs, however,
did not yield a significant difference.[3] Increased QTc interval
and the presence of left bundle branch block were also associated
with higher vascular mortality rates in patients with right-sided
insular infarcts.[4] These clinical implications of disturbances of
the brain-heart-axis should encourage for heightened sensitivity in
the acute hospitalization period in regards to selection of patients
especially vulnerable towards cardiac abnormalities that may
profit from a more stringent cardiological work-up and/or early
detection devices amongst others implantable loop recorders. [12].
Since it is not possible to ascertain whether our patients with
newly diagnosed AF had already experienced AF episodes before
the stroke, we cannot make any inferences regarding causality.
However, it is biologically plausible that an insular stroke in
patients with paroxysmal subclinical AF or with other pre-existing
but clinically unapparent cardiac dysfunction may, via activation
of the sympathetic nervous system, trigger longer episodes of AF or
may convert into AF, which then can be detected by monitoring.
Thus, insular lesions in acute stroke patients with elevated plasma
MR-proANP levels should prompt an aggressive cardiac work-up
and potentially even outpatient monitoring to increase the yield for
the detection of AF also in patients where the stroke etiology was
not believed to be cardioembolic.
In a pilot study, mid-regional ANP precursor protein has been
proven to represent a promising biomarker for determining the
duration of AF episodes. More specifically, MR-proANP levels
were higher in patients with AF episodes lasting longer than
48 hours compared to patients with episodes of less than 48 hours
duration (321.7 IQR 236.4–425.6 versus 144.0 IQR 129.2–213.7
[pmol/L].[7] In our study, patients with elevated lnMR-proANP
levels had 5.03-fold greater odds of having newly-diagnosed atrial
fibrillation. Levels of brain natriuretic peptide (BNP) have been
shown to be higher in patients where NDAF was documented
during the hospitalization period. This association was indepen-
dent of age, NIHSS and female gender.[22] In another more
recently published retrospective analysis from the Warfarin-Aspirin
recurrent stroke study, patients with plasma concentrations of amino-
terminal pro-BNP (NT-proBNP) over 750 pg/mL seemed to be at
lower risk for subsequent events (i.e. recurrent ischemic stroke or
death over 2 years) when treated with anticoagulants other than
antiplatelet agents.[23] These findings underscore the role of
natriuretic peptides as serum markers of impending cardiac
arrhythmias and assist in their clinical management. Although in
our study, a significant difference in MR-proANP levels was
detected between patients from cohort A with ischemic strokes
involving the insula and those without, insular strokes failed to be
predictive for MR-proANP levels in linear regression analyses with
and without lesion size stratification (data not shown). This suggests
that the association of insular strokes with new onset of AF is not in
the same causal pathway as MR-proANP and AF. Another
explanation is that we were underpowered and therefore unable to
find any type of mediation.
Some limitations merit attention. First, newly-diagnosed atrial
fibrillation in insular stroke patients was not the primary endpoint
of the original study cohort; however, all data were prospectively
collected and biomarker measurements were pre-planned and
assessed in a blinded manner. Second, we did not collect
information on NDAF after discharge, thus we may have missed
some patients with insular strokes and/or elevated MR-proANP
levels that did not show signs of new-onset atrial fibrillation during
their hospitalization but suffer from intermittent atrial fibrillation.
[24] Hence this potential misclassification is more likely to
underestimate the association of insular strokes with NDAF (i.e.
bias towards the null-hypothesis) because in the group without
NDAF some patients might have had atrial fibrillation thus raising
the number of false negatives. Thirdly, due to sample size
limitations, we did not assess insular substructures, such as
anterior/posterior division or laterality, although some studies
have investigated this complex and controversial topic of
specifically assigned parts of the insula.[25] Finally, the results of
this pilot study should be interpreted with caution due to the
relatively small numbers thus an external validation in an
independent larger cohort is necessary. Still, these promising
results should propagate further investigation with larger patient
cohorts since our findings could be of practical clinical value for
the early identification of AF patients which might benefit from
oral anticoagulation.
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